



Aboriginal Health
Adolescent Medicine
Anaesthetics
Complementary Medicine
Dermatology
Drugs and Alcohol
ENT
Geriatrics
ICU
Internal Medicine
Musculoskeletal
Paediatrics
Palliative Care
Psychiatry
Sexual Health
Surgery
Women's Health
Emergency
 NeedleStick Injuries
 Overdose & Poisoning
|
|
Table of Contents
NeedleStick Injuries
|
What is your role when someone presents to your practice after a
needlestick injury or any other hazardous exposure to blood or other
body substance?
In cases where the person who is the source of the exposure is
known to be HIV, hepatitis B or hepatitis C positive, you need to
urgently contact a physician with experience in managing these
infections. Combination antiretroviral therapy is now recommended for
some HIV exposures and the selection of appropriate agents should be
decided in consultation with the physician. Contact NSW Health Needle
Stick hotline 1 800 804 823 for assistance.
Following is a brief description of the course of action to take
for an uncomplicated needlestick injury where the original user of
the needle is unknown.
Your initial efforts need to be directed at reducing the risk of
the exposed patient contracting an infectious illness. Immediate
first aid is required if the event is recent and if the patient has
not already done this. The accompanying checklist specifies first aid
steps to follow and some prophylactic medications to offer.
The next step is to collect blood from the patient for baseline
testing after counselling and obtaining informed consent.
A thorough assessment of the exposure is then required to
determine the risk of disease transmission. Reassure the patient that
only a small proportion of blood exposures result in infection.
It is impossible to precisely determine this risk, but factors
that have been identified as being associated with HIV transmission
include:
- terminal AIDS illness in the source person,
- deep injury, visible blood on device, procedure involving
needle placed directly into a vein or artery.
The following estimates of disease transmission rates from
percutaneous injuries have been made for occupational exposures and
these may be used as a guide in explaining the risk to the patient.
|
HIV
|
0.2-0.5%
|
Hepatitis B - HBeAg absent
- HBeAg present
(prompt administration of HBIG and hepatitis B
vaccination can prevent transmission in most cases)
|
2%
40%
|
Hepatitis C
(2 separate studies with small samples) (Ref
1)
|
3-10%
|
Your next step is to advise the patient about the precautions to
take until final testing confirms lack of disease transmission.
Precautions and testing schedules are listed below. Counselling
should be offered during this worrying period.
Finally, in the unfortunate event of disease transmission
occurring, the patient may call on you for evidence in support of
their claim that transmission was related to the exposure injury.
Your documentation and the patient's negative baseline test results
provide this evidence.
Consider the following scenario. A patient attends your practice
after treading on a needle and syringe while walking through
parkland. What action do you take?
Body substance exposure accidents to GPs or co-workers in the
practice setting require similar management to that described above.
Often in these circumstances the person who is the source of the
injury is known, and can therefore be approached for testing if their
status is not already known. Approaching the person who is the
unwitting source of an exposure requires sensitivity. The
circumstances of these exposures should be investigated and action
taken to prevent recurrence. This may lead to changes in work
practices, changes to equipment or education.
Needlestick injury - management of exposed
person
CHECKLIST
1. REVIEW THE CIRCUMSTANCES OF THE EXPOSURE
Determine how long ago the incident occurred
Determine the nature and degree of exposure
- whether skin was punctured, bleeding occurred
(examine for skin perforation)
- depth of needle penetration
- whether the needle or syringe was visibly blood
contaminated
Determine First Aid response
- was the site washed immediately, how?
- wash, disinfect and consider surgical treatment if
the wound is tetanus prone
2. ASSESS RISK, COUNSEL AND EDUCATE PATIENT
Assess the degree of exposure
Reassure the patient that the risk of disease
transmission is small
Advise that consideration should be given to the
following:
- need to avoid donating blood, organs or semen
- possibility of risks associated with breast
feeding, pregnancy
Explain precautions to avert disease transmission to
close contacts eg safe sex, no sharing of toothbrushes or
any item which may be blood contaminated.
3. PROVIDE POST EXPOSURE PROPHYLAXIS
(normally)
Hepatitis B immune globulin (HBIG), IM, if less than 72
hours from time of exposure injury.
Hepatitis B vaccination, IM (separate site from HBIG)
Tetanus vaccination - use of CDT (children < 8)or ADT
(persons over 8 years), with or without tetanus
immunoglobulin will be based on tetanus immunisation history
and the type of wound.
Refer to NHMRC, The Australian immunisation procedures
handbook, Fifth edition (1994) , p.30 (tetanus) & p. 67
(hepatitis B) for post-exposure prophylaxis guidelines.
4. COLLECT BLOOD FOR BASELINE TESTING
(after counselling and obtaining informed consent)
Request HIV Ab, Anti-HCV, and HBcAb if the patient is not
vaccinated, or HBsAb if already vaccinated
Provide history on HIV testing form and on routine
serology request forms eg ìNeedlestick injury -
exposed person, not hepatitis B vaccinatedî.
Forms are ideally coded.
5. FOLLOW UP
Arrangements should be made to:
Complete the full course of hepatitis B vaccination
followed by antibody testing at 2-4 months after completion
of the vaccine course
Retest for HIV Ab (at 3 months), hepatitis B and
hepatitis C (at 3 and 6 months)
6. DOCUMENTATION
Date and time of exposure/injury
Circumstances of the injury
First aid applied
Risk assessment and explanations given to the patient
Tests ordered
Prophylactic antimicrobial medications administered
Follow up arrangements for receiving test results and
continuing vaccinations
Precautions advised during follow up period.
NOTE: Confidentiality must be maintained at all times.
|
Becky Wright
Infection control project officer, NRDGP
Reference:
1 Gerberding JL. Management of occupational
exposures to blood-borne viruses. N Engl J Med 1995;332:444-51.
|